Trenbolone Acetate 100 er et populært steroid blandt bodybuildere og atleter, der ønsker at forbedre deres præstationer og muskelvækst. Det er kendt for sin evne til at fremme muskelopbygning og forbedre styrken på kort tid, hvilket gør det til et eftertragtet valg i fitnessverdenen.
Hjemmesiden Trenbolone Acetate 100Bivirkninger tilbyder udførlige oplysninger om Trenbolone Acetate 100 og dets anvendelse i sport.
Fordele ved Trenbolone Acetate 100
Muskelvækst: Trenbolone Acetate 100 hjælper med at øge muskelmasse hurtigt og effektivt.
Forbedret styrke: Mange brugere rapporterer betydelige forbedringer i deres styrke, hvilket gør det lettere at løfte tungere vægte.
Reduceret fedt: Det hjælper også med at reducere body fat, hvilket bidrager til en mere defineret muskelmasse.
Øget udholdenhed: Trenbolone kan forbedre den generelle udholdenhed, så atleter kan træne hårdere og længere.
Risici og bivirkninger
Sammen med fordelene ved Trenbolone Acetate 100 kommer der også potentielle bivirkninger. Det er vigtigt for brugerne at være opmærksomme på disse, herunder:
Akne og hudproblemer
Øget aggression og humørsvingninger
Problemer med søvn
Mulige hormonelle ændringer, herunder påvirkning af testosteronniveauer
Brug og dosering
Når det kommer til brug og dosering af Trenbolone Acetate 100, er det vigtigt at følge anvisningerne nøje og konsultere med en fagperson. En typisk dosis for begyndere kan være mellem 50-100 mg pr. uge, men erfarne brugere kan tage højere doser. Det anbefales også at kombinere det med andre stoffer for optimal effekt, men dette bør også gøres under vejledning af eksperter.
At tage Trenbolone Acetate 100 er ikke uden sine udfordringer, men med den rette tilgang og viden kan det være et værdifuldt redskab i jagten på muskler og styrke. Husk altid at prioritere din sundhed og sikkerhed først.
Evidence-Based Approaches to Tendinopathy Treatment: What the LiteratureSupports
Tendinopathy is a common yet challenging condition affecting athletes, active individuals, and those with repetitive strain injuries. At Elevated Medicine, we prioritize evidence-based, regenerative approaches to help patients recover and regain optimal longterm function. As research evolves, it’s crucial to understand which treatments are supported by recent literature and which may offer more temporary benefits. Let’s explore the latest findings on various treatment options, including NSAIDs, corticosteroids, platelet-rich plasma (PRP), autologous blood injections, prolotherapy, and extracorporeal shockwave therapy (ESWT).
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
NSAIDs are often a first-line treatment for tendinopathy, as they help reduce pain and decrease the inflammatory response. However, there appears to be sufficient evidence to suggest that NSAIDs negatively impact the enthesis, which is the attachment of a tendon, ligament, joint capsule, or fascia to bone. This is significantly influenced by the type of NSAID used and duration of therapy. There is also literature that suggests NSAIDs may negatively impact tenocyte differentiation and proliferation. Tenocytes are responsible for maintaining the structural integrity and function of tendons by secreting components that make up the highly organized, dense, fibrous tissue. For patients who have tried a course of NSAIDs without improvement or would prefer to avoid NSAIDs and are looking for solutions, the regenerative therapies discussed below may offer better outcomes.
Corticosteroid Injections
Corticosteroids have been widely used for tendinopathy due to their powerful anti- inflammatory effects. However, multiple studies indicate that while they may provide short-term pain relief, they often lead to worse long-term outcomes. There is a hight rate of reoccurrence with corticosteroid injections ranging from 54-72% when referencing the studies below. They have also been shown to weaken tendon structure, contribute to further degeneration, and in rare cases cause tendon rupture. Their use should be carefully considered after weighing the risks and benefits based on the patient’s individual risk factors, type of injury, age, and activity level.
Platelet-Rich Plasma (PRP)
PRP therapy has gained significant traction as a regenerative treatment for tendinopathy with minimal complications and adverse outcomes. PRP is derived from a patient’s own blood by separating the plasma from the red blood cells and concentrating it in a centrifuge. If done properly, this process yields a high concentration of platelets, which contain growth factors that are thought to promote tissue repair and healing. The recent literature supports PRP as a promising alternative for certain injuries, with multiple studies demonstrating its efficacy in reducing pain, improving tendon function and strength through a regenerative process. This therapy is particularly beneficial in
chronic tendinopathies such as lateral epicondylitis (tennis elbow) and patellar tendinopathy. However, there is still some variability in outcomes most likely due to the lack of standardization of PRP preparation, concentration of platelets, and precision of injection. Regardless, this therapy remains one of the most promising non-surgical options available. At Elevated Medicine, we ensure the highest quality PRP processing kits, yielding consistent and high doses of platelets. These are precisely placed into the injury via ultrasound guidance for the best chance at optimal, long-lasting results.
Autologous Blood Injections
Autologous blood injections (ABI) involve injecting a patient’s own whole blood directly into the affected tendon to stimulate healing. Like PRP, ABI introduces growth factors that may aid in tendon repair, though PRP is often considered more potent due to its higher concentration of platelets. Some studies suggest ABI may be effective in treating tendinopathy, but PRP generally demonstrates superior results. Nevertheless, ABI remains a viable option, particularly when PRP is not readily available or cost- prohibitive.
Prolotherapy
Prolotherapy involves injecting an irritant solution, often dextrose-based, into the affected tendon to stimulate the body’s natural healing response. Emerging research supports its use in tendinopathy by promoting collagen deposition and tissue repair. While not as extensively studied as PRP, prolotherapy has shown promise, particularly in chronic cases where conventional treatments have failed. This approach may be particularly beneficial when combined with other regenerative therapies.
Extracorporeal Shockwave Therapy (ESWT)
ESWT has gained recognition as an effective, non-invasive treatment for tendinopathy. By delivering high-energy shockwaves to the affected tendon, it is thought ESWT stimulates blood flow, collagen production, and tissue regeneration. Research supports its efficacy in reducing pain and improving function in patients with chronic tendinopathies such as plantar fasciitis, achilles tendinopathy, and lateral epicondylitis. ESWT is particularly beneficial when used in combination with other regenerative treatments, such as PRP or physical therapy, to enhance recovery. At Elevated Medicine, this is often performed in conjunction with other regenerative techniques as part of a comprehensive, multimodal approach.
The Elevated Medicine Approach: An Individualized Multimodal Regenerative Strategy
At Elevated Medicine, we take a comprehensive, patient-centered approach to tendinopathy treatment. Rather than relying solely on temporary pain relief strategies, we focus on regenerative therapies that address the root cause of tendon degeneration. PRP, ABI, prolotherapy, and ESWT have all shown promise in restoring tendon health
and function, and we carefully tailor treatment plans based on the latest scientific evidence and each patient’s unique needs. If you’re struggling with chronic tendon pain and are looking for an effective, science- backed approach to healing, schedule a consultation with Elevated Medicine today. We look forward to working together to restore your movement, function, and quality of life.
NSAID References:
Fede C, Albertin G, Petrelli L, et al. Altered tensile strain induces inflammation-like response in tenocytes. J Appl Physiol (1985).* 2018;124(5):1353-1360. doi:10.1152/japplphysiol.00281.2017. Available from: [https://journals.physiology.org/doi/full/10.1152/japplphysiol.00281.2017](https://journals. physiology.org/doi/full/10.1152/japplphysiol.00281.2017)
Dakin SG, Newton J, Martinez FO, et al. Chronic inflammation is a feature of Achilles tendinopathy and rupture. Br J Sports Med.* 2018;52(6):359-367. doi:10.1136/bjsports- 2017-098161. Available from: [https://pubmed.ncbi.nlm.nih.gov/33719579/](https://pubmed.ncbi.nlm.nih.gov/33719579 /)
Magnusson SP, Langberg H, Kjaer M. The pathogenesis of tendinopathy: balancing the response to loading. Br J Sports Med.* 2010;48(21):1553-1559. doi:10.1136/bjsports-2013-092656. Available from: https://bjsm.bmj.com/content/48/21/1553
Soslowsky Laboratory. Effects of NSAIDs on Tendon Healing. University of Pennsylvania Orthopedic Research Laboratory. Available from: [https://www.med.upenn.edu/orl/soslowskylab/nsaid.html](https://www.med.upenn.edu/o rl/soslowskylab/nsaid.html)
Andersson G, Forsgren S, Scott A, Gaida JE, Stjernberg T, Danielson P. Tenocyte hypercellularity and vascular proliferation in a rat model of Achilles tendinopathy: Contralateral changes and the role of NGF. J Rehabil Med. 2011;43(6):526-533. doi:10.2340/16501977-1800. Available from: https://www.medicaljournals.se/jrm/content/html/10.2340/16501977- 1800
Corticosteroid References:
Bisset L, Beller E, Jull G, Brooks P, Darnell R, Vicenzino B. Mobilization with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomized trial. BMJ. 2006;333(7575):939. doi:10.1136/bmj.38961.584653.AE. Available from: https://www.bmj.com/content/333/7575/939
Coombes BK, Bisset L, Vicenzino B. Corticosteroid injections for the treatment of lateral epicondylitis: a systematic review and meta-analysis. Am J Sports Med. 2010;38(12):2553-2565. doi:10.1177/0363546510378106. Available from: [https://scholars.uthscsa.edu/en/publications/corticosteroid-injections-for-the-treatment-of-lateral- epicondyli](https://scholars.uthscsa.edu/en/publications/corticosteroid-injections-for-the-treatment-of- lateral-epicondyli)
Kamel SI, Rosas HG, Gorbachova T. Local and Systemic Side Effects of Corticosteroid Injections for Musculoskeletal Indications. AJR Am J Roentgenol. 2024;222(3):e2330458. doi:10.2214/AJR.23.30458. Available from: [https://www.ajronline.org/doi/10.2214/AJR.23.30458](https://www.ajronline.org/doi/10.2214/AJR.23.3045 8)
Andres BM, Murrell GA. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin Orthop Relat Res.* 2008;466(7):1539-1554. doi:10.1007/s11999-008-0260-1. Available from: https://pubmed.ncbi.nlm.nih.gov/23385272/
Scott A, Squier K, Alfredson H, et al. ICON 2019: International Scientific Tendinopathy Symposium Consensus: There are nine core health-related domains for tendinopathy (CORE DOMAINS): Delphi study of healthcare professionals and patients. Br J Sports Med. 2020;54(8):444-451. doi:10.1136/bjsports-2019-100884. Available from: https://pubmed.ncbi.nlm.nih.gov/27469590/
Platelet-Rich Plasma (PRP) References:
Effectiveness of Lateral Elbow Tendinopathy Treatment Depends on the Content of Biologically Active Compounds in Autologous Platelet-Rich Plasma. J Clin Med. 2022;11(13):3687. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9267331/
Platelet-Rich Plasma Injection in Non-Operative Treatment of Partial-Thickness Rotator Cuff Tears: A Systematic Review and Meta-Analysis. J Rehabil Med. 2022;54:1434. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9495266/
Effectiveness of Lateral Elbow Tendinopathy Treatment Depends on the Content of Biologically Active Compounds in Autologous Platelet-Rich Plasma. J Clin Med. 2022;11(13):3687. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9267331/
Platelet-Rich Plasma Injection in Non-Operative Treatment of Partial-Thickness Rotator Cuff Tears: A Systematic Review and Meta-Analysis. J Rehabil Med. 2022;54:1434. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9495266/
Effectiveness of Lateral Elbow Tendinopathy Treatment Depends on the Content of Biologically Active Compounds in Autologous Platelet-Rich Plasma. J Clin Med. 2022;11(13):3687. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9267331/
Platelet-Rich Plasma Injection in Non-Operative Treatment of Partial-Thickness Rotator Cuff Tears: A Systematic Review and Meta-Analysis. J Rehabil Med. 2022;54:1434. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9495266/
Autologous Blood Injection References:
Rees JD, Stride M, Scott A. Tendons–time to revisit inflammation. Br Med Bull. 2010;95(1):63-94. doi:10.1093/bmb/ldq035. Available from: https://academic.oup.com/bmb/article- abstract/95/1/63/269316
Barnett J, Bernacki MN, Kainer JL, Smith HN, Zaharoff AM, Subramanian SK. The effects of regenerative injection therapy compared to corticosteroids for the treatment of lateral epicondylitis: a systematic review and meta-analysis. Arch Physiother. 2019;9:12. doi:10.1186/s40945-019-0063-6. Available from: https://pubmed.ncbi.nlm.nih.gov/30899764/
Vander Doelen T, Jelley W. Non-surgical treatment of patellar tendinopathy: a systematic review of randomized controlled trials. J Sci Med Sport. 2020;23(2):118-124. doi:10.1016/j.jsams.2019.09.008. Available from: https://pubmed.ncbi.nlm.nih.gov/31754461/
Prolotherapy References:
Sanderson LM, Bryant A. Effectiveness and safety of prolotherapy injections for management of lower limb tendinopathy and fasciopathy: a systematic review. J Foot Ankle Res. 2015;8(1):57. doi:10.1186/s13047-015-0114-5. Available from: https://pubmed.ncbi.nlm.nih.gov/26500703/
Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. A systematic review of dextrose prolotherapy for chronic musculoskeletal pain. Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:139-159. doi:10.4137/CMAMD.S39160. Available from: https://pubmed.ncbi.nlm.nih.gov/27429562/
Miettinen J, Järvinen T, Kallio J, et al. Effectiveness of extracorporeal shock wave therapy on chronic musculoskeletal disorders: A systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2018;21(4):305-316. Available from: [https://pmc.ncbi.nlm.nih.gov/articles/PMC9382436/?utm]( https://pmc.ncbi.nlm.nih.gov/articles/PMC93824 36/? )
Elgendy MH, Elhakeem A, Fares A, et al. The effect of extracorporeal shock-wave therapy on pain in patients with various tendinopathies: a systematic review and meta-analysis of randomized controlled trials. BMC Sports Sci Med Rehabil. 2024;16(1):84. doi:10.1186/s13102-024-00884-8.
Elgendy MH, Elhakeem A, Fares A, et al. The effect of extracorporeal shock-wave therapy on pain in patients with various tendinopathies: a systematic review and meta-analysis of randomized controlled trials. BMC Sports Sci Med Rehabil. 2024;16(1):84. doi:10.1186/s13102-024-00884-8. Available from: https://bmcsportsscimedrehabil.biomedcentral.com/articles/10.1186/s13102-024-00884- 8?utm_
Doherty TJ, Berryman R, Jackson JL, et al. Extracorporeal shock wave therapy in veterinary medicine: a comprehensive review. Front Vet Sci. 2022;9:851894. doi:10.3389/fvets.2022.851894. Available from: [https://www.frontiersin.org/journals/veterinary- science/articles/10.3389/fvets.2022.851894/full?utm](https://www.frontiersin.org/journals/veterinary- science/articles/10.3389/fvets.2022.851894/full?utm)
Guy’s and St Thomas’ NHS Foundation Trust. Extracorporeal shockwave therapy for Achilles tendinopathy and plantar fasciitis. Available from: [https://www.guysandstthomas.nhs.uk/health- information/extracorporeal-shockwave-therapy-achilles-tendinopathy-and-plantar- fasciitis](https://www.guysandstthomas.nhs.uk/health-information/extracorporeal-shockwave-therapy- achilles-tendinopathy-and-plantar-fasciitis)
Have you heard of platelet rich plasma (PRP) and bone marrow concentrate (BMC) treatments? They are becoming increasingly popular for the treatment of orthopedic injuries. In this article, we will discuss what these treatments are, how they improve healing, and whether or not they can help with your orthopedic injury. #prp
What is Platelet Rich Plasma?
Platelet Rich Plasma (PRP) is a type of therapy that involves extracting a small volume of red blood cells, which are then concentrated in a centrifuge to separate the red blood cells, platelets, and plasma. Depending on the type and location of injury, certain components such as leukocytes (immune cells) may be removed or kept. Once the concentrated mixture is separated (often referred to as “liquid gold”), it’s precisely injected or transplanted into the site of injury. The concentrated platelets found in PRP contain growth factors that help to promote healing and tissue regeneration. PRP injections can be used to treat a variety of orthopedic injuries, including tendonitis, muscle strains, ligament tears, joint pain and arthritis.
How Does PRP Improve Healing?
When injected into an injured area, PRP helps to reduce inflammation while modifying the production of collagen fibers in the affected area. This helps to speed up the recovery process by decreasing pain and improving mobility faster than most traditional treatments alone. In turn, the goal is to improve your quality of life by getting you back to the activities you enjoy the most. Likewise, results often last longer compared to corticosteroid injections without compromising the musculoskeletal tissue.
What is Bone Marrow Concentrate?
Bone marrow concentrate (BMC) is a type of therapy similar to PRP in that it also uses a patient’s own cells as part of the treatment process. In BMC treatments, however, the cells come from bone marrow rather than blood plasma. Unlike PRP injections which only use platelets, BMC injections contain both platelets as well as stem cells which can help with tissue regeneration and healing.
How Does BMC Improve Healing?
Like PRP injections, BMC injections have been shown to reduce inflammation while speeding up recovery times due to its ability to stimulate healthy tissue response in damaged areas. It also has the added benefit of scar reduction due to its ability to promote healthy cell development when injected into an injured area. Additionally, BMC has been shown to be more effective at improving outcomes in certain injuries when compared with other traditional therapies.
Will These Treatments Help With Your Orthopedic Injury?
Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC) treatments offer many potential benefits for those suffering from orthopedic injuries such as tendonitis, muscle strains, partial ligament tears/sprains or mild to moderate arthritis. Both types of treatments have been proven effective at reducing inflammation while promoting healing and restoring mobility faster than traditional treatments alone. If you are considering these types of treatments for your orthopedic injury it is important that you speak with your doctor first so they can evaluate your specific situation before recommending an appropriate course of treatment for you. Please keep in mind that there is no current treatment modality in medicine that is 100% successful in every patient. Some individuals require 2-3 injections before noticing significant improvement. Additionally, your overall health and lifestyle will impact the quality of platelets and cells extracted. We are happy to discuss the best treatment options for you.
What You Need to Know About PRP Quality and Underlying Medical Conditions, Medications, and Lifestyle Factors
Platelet-rich plasma (PRP) therapy is a regenerative medical treatment that has been used for many years to treat various chronic pain conditions. It is based on the idea of using the body’s own natural healing powers to assist in repair of damaged tissue and reduce inflammation. In recent years, PRP has become increasingly popular as an alternative treatment option for many common medical conditions. In this article, we will discuss some of the medical conditions that can impact the effectiveness of PRP treatments, as well as which patients respond best to this type of therapy.
Medical Conditions That Impact PRP Outcomes:
The current physiological status of the patient, or how efficiently the machine (or human body) is functioning, is a key consideration when evaluating the effectiveness of the treatment. Certain medical conditions can make it difficult for the body to absorb platelet-rich plasma or make it hard for the body to produce enough platelets. For example, people with chronic conditions such as poorly controlled diabetes, peripheral vascular disease, uncontrolled hypertension (high blood pressure), or heart failure may not be able to respond as effectively to PRP treatments since their bodies are already impacted with diminished circulation and reduced platelet quality. Additionally, people with autoimmune disorders such as lupus or rheumatoid arthritis may be unable to produce enough platelets for successful PRP treatments. Finally, certain medications can decrease platelet production and/or function. A few examples include NSAID’s, selective serotonin reuptake inhibitors (SSRI’s), antihistamines, antibiotics, and tricyclic antidepressants.
Diet and Lifestyle Factors That Impact PRP Outcomes:
Nutrition plays a large role in the quality of platelets your body produces. Diets high in processed foods, sugar, simple carbohydrates, and omega 6 fatty acids (found in industry seed oils) can impact platelet activation, production, and aggregation. All of these factors are important in the overall quality of PRP and in turn, your natural healing response. Additionally, excessive alcohol consumption and tobacco use can reduce the platelets response to thrombin and collagen, making them less effective. Lastly, physical and mental stress induces a spike in hormones such as adrenalin, noradrenaline, and serotonin, which impacts the platelets sensitivity to thrombin, factor release, and aggregation. High intensity exercise prior to your procedure can induce physical stress and potentially impact your treatment.
Patients Who Respond Best To PRP Treatments:
Similarly to invasive surgical outcomes, individuals who strive to live a healthy lifestyle by incorporating routine exercise, a well-rounded diet low in processed foods, and adequate sleep will respond best. However, our patients with multiple underlying medical problems are at higher risk for surgical complications and oftentimes minimally invasive procedures can provide pain relief and improved functionality. Utilizing precision medicine, we strive to optimize all modifiable factors prior to treatment for optimal results.
In conclusion, there are several medical conditions, medications, and lifestyle factors that can affect how effective a patient’s response is when undergoing a course of platelet-rich plasma (PRP) therapy. Despite all this, there are still many patients who respond very positively when undergoing courses of treatment involving PRP therapy; those suffering from chronic pain conditions such as tendinitis or bursitis often see great improvement in their symptoms after undergoing one or multiple rounds of treatment while athletes can use it help improve performance during competitions as well as reducing inflammation afterward. When considering PRP, we would highly suggest seeking out physicians who understand the relationship between platelets and other medical/lifestyle factors to ensure the best possible outcome.
Kuffler DP. Variables affecting the potential efficacy of PRP in providing chronic pain relief. J Pain Res. 2018 Dec 21;12:109-116.
Barkin RL, Fawcett J. The management challenges of chronic pain: the role of antidepressants. Am J Ther. 2000;7(1):31–47.
George JN. Platelets. Lancet. 2000;355(9214):1531–1539.
Ahmed Y, van Iddekinge B, Paul C, Sullivan HF, Elder MG. Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol. 1993;100(3):216–220.
Mukamal KJ, Massaro JM, Ault KA, et al. Alcohol consumption and platelet activation and aggregation among women and men: the Framingham Offspring Study. Alcohol Clin Exp Res. 2005;29(10):1906–1912.
Belch JJ, McArdle BM, Burns P, Lowe GD, Forbes CD. The effects of acute smoking on platelet behavior, fibrinolysis and haemorheology in habitual smokers. Thromb Haemost. 1984;51(1):006–008.
Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001;344(17):1286–1292.
de Lorgeril M, Renaud S, Mamelle N, Salen P, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343(8911):1454–1459.
Sudic D, Razmara M, Forslund M, Ji Q, Hjemdahl P, Li N. High glucose levels enhance platelet activation: involvement of multiple mechanisms. Br J Haematol. 2006;133(3):315–322.
Platelets can be thought of as the first responders or ambulances of your body, carrying paramedics and EMT’s to the site of injury. They help to form the clotting system that is essential for our body’s natural healing process. However, platelets are more than just a clotting factor – they also contain bioactive molecules and contain various proteins that can be used therapeutically. In this article, we will discuss platelet rich plasma (PRP), how it is activated and its therapeutic potential.
What are Platelets?
Platelets are produced by cells called megakaryocytes that live in the bone marrow. They have a lifespan of 7-10 days in the bloodstream. They carry receptors on their plasma membrane (outer coating) that allow them to perform their wide variety of functions. These receptors bind to von Willebrand Factor (VWF) and collagen when there is injury to the endothelium (single layer of cells lining the entire surface of the cardiovascular and lymph circulations). When the platelet interacts with the site of injury, they change shape and can bind to other platelets, tissue, and fibrinogen (found in inflamed joint tissue). This is part of platelet activation and aggregation. Once platelets are activated, they release the powerful contents held within, that have regenerative capabilities.
The contents inside the platelets include granules, or little packets of active bioactive molecules important in tissue repair. These molecules include growth factors, exosomes, antimicrobial substances, adhesive proteins, among many others. Each of these have unique roles in promoting blood vessel formation, cellular proliferation, and recruitment of other cells to assist in repair. The exosomes in particular are tiny little packages, or vesicles that are critical in cell communication and reduction of inflammation.
Some other important growth factors include:
-TGF-B: aids in differentiation of mesenchymal stem cells (MSC’s), which are multipoint stem cells important in making and repairing all skeletal tissue.
-PDGF: recruits multiple other cells types to injury site and is important in cartilage and meniscus repair
-VEGF: stimulates formation of blood vessels
-EGF: initiates cell growth and differentiation
-IGF-1 and HGF: responsible for stimulating cell growth
If you’ve made it this far, you’re probably thinking, “These little first responders are complex!”, and you’re absolutely correct. We have learned a significant amount about the importance of platelets in tissue and injury repair in the past few decades. With the increasing popularity of PRP, there are numerous ongoing trials and still a lot to discover. This is a very exciting and promising field of medicine that has provided significant improvement in certain patients’ lives.
Because these treatment modalities utilize your own body’s components, there are minimal risks associated, making it an excellent option for those looking for alternative treatments for their conditions without compromising safety or efficacy when compared with traditional therapies alone. If you’re interested in learning more about how PRP can benefit you, contact us today!
Machlus KR, Italiano JE Jr. The incredible journey: From megakaryocyte development to platelet formation. The Journal of Cell Biology. 2013;201(6):785-796. DOI: 10.1083/jcb.201304054
Gremmel T, Frelinger AL 3rd, Michelson AD. Platelet physiology. Seminars in Thrombosis and Hemostasis. 2016;42(3):191-204. DOI: 10.1055/s-0035-1564835
Padilla S, Sánchez M, Orive G, Anitua E. Human-based biological and biomimetic autologous therapies for musculoskeletal tissue regeneration. Trends in Biotechnology. 2017;35(3):192-202
